phrma project on government interventions in pharmaceutical markets oecd countries overview of july 1 2004 the boston consulting group fr_submission_ interventions_01jul04 ppt context for this material these slides summarize selected findings a study commissioned by and conducted between april may objective was to evaluate impact cost controls non us consumer economy inform policy debate medicare prescription drug improvement modernization act mma 2003 our drew four main strands research detailed review approaches taken cross cutting sample controlling costs canada france germany japan poland spain united kingdom states survey extensive literature including academic studies reports analysis primary data from ims set classes anti diabetics psychotics statins select cancer agents series interviews with executives list u k
